Latest News

Investors are having a negative reaction to Applied Digital's latest fundraising moves.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflected growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

Solana ETFs have seen $350M inflows, boosting institutional demand.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflects growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, which were perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

A number of stocks jumped in the afternoon session after investors continued to pile into value-oriented names amid growing valuation concerns. This shift reflects growing caution over high valuations within the technology and artificial intelligence (AI) spheres. As market participants reassessed risk, they reallocated capital from growth-heavy indices, like the Nasdaq, to companies in areas like industrials and financials, which were perceived to be more reasonably priced. Contributing to the positive momentum, markets remained hopeful that a prolonged 40-day government shutdown would be over. The U.S. Senate approved a compromise funding package, which was pending a vote in the House. The potential end to the shutdown brought a sense of relief to markets.

Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.9% in the afternoon session after the stock's positive momentum continued as the company reported impressive financial results for the third quarter of 2025, showing resilient performance and robust sales growth. In its earnings report from the previous day, the company disclosed net revenues of $191.8 million for the quarter. Furthermore, its adjusted net income reached $44.7 million, which translated to $0.93 per diluted share. This performance underscored the company's strong financial health, even as it navigated challenges like increased competition and sales declines in certain product areas. The positive results appeared to give investors confidence in the company's standing.

Shares of environmental waste treatment and services provider Perma-Fix (NASDAQ:PESI) fell 10.8% in the afternoon session after the company reported third-quarter results that revealed a significant revenue decline in its Services segment. That segment's revenue fell to $4.3 million from $7.7 million in the same period of the previous year. The company stated this drop was mainly due to delays in Department of Energy and Department of Defense projects, along with slower timing for new awards. Adding to investor concerns, Perma-Fix noted that its expansion into the PFAS market was progressing slower than initially hoped. The company also reported a non-GAAP loss of $0.10 per share during the quarter. These challenges appeared to outweigh positive results in other areas, such as the Treatment segment.

Shares of infrastructure investment and operations firm FTAI Infrastructure (NASDAQ:FIP) fell 6% in the afternoon session after the stock's negative momentum continued as the company reported disappointing third-quarter 2025 financial results, missing analyst expectations for both revenue and earnings. The company's revenue for the quarter was $140.6 million, falling short of the $146.4 million analysts had forecast. The earnings miss was more significant, with a reported loss per share of $1.38, which was much wider than the estimated loss of $0.59 per share. Overall, the net loss attributable to stockholders widened to $118.4 million. The company pointed to higher expenses, integration costs, and increased interest expense as reasons for the larger loss. Additionally, the company's financial health showed other signs of strain, as its operating margin fell sharply to -70.8% from -5.3% in the same period of the previous year, and its free cash flow was a negative $90.71 million.

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) fell 7.5% in the afternoon session after the market continued to react negatively to the company's third-quarter financial results, which missed Wall Street expectations. Management pointed to a slowdown in instrument shipments, especially its Vega systems in Europe, and lower average selling prices for its Revio systems as the main reasons for the underperformance. The company's CEO also described the funding environment in the Americas as “challenging,” which made it take longer for some academic and government research customers to make purchases. Adding to investor concerns, the company is not yet profitable and reported a net loss of $38 million in the last quarter.

Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 7.3% in the afternoon session after its third-quarter earnings report revealed a weak financial outlook, which prompted a lower price target from analysts. Although the healthcare data analytics company beat Wall Street's revenue expectations, sales were flat compared to the previous year. More importantly, the company's revenue guidance for the next quarter came in below analysts' estimates, and its forecast for 2026 suggested a continued sales decline. Investors were concerned by several headwinds facing the company, including challenges in migrating clients to a lower-cost platform and pressure on customer retention. The company's professional services revenue also fell, and its cash reserves saw a significant decrease. In response to the weak outlook, analysts at Stifel lowered their price target on the stock, and other analysts also revised their earnings estimates downward.

Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 10.3% in the afternoon session after Oppenheimer significantly lowered its price target on the stock. The investment firm cut its view on the stock's future price from $18.00 to $12.00, a notable 33.33% reduction. The substantial cut in the price target likely raised concerns among investors about the company's near-term prospects, contributing to the stock's decline.

Shares of luxury electric car manufacturer Lucid (NASDAQ:LCID) fell 5% in the afternoon session after the company announced the pricing of an $875 million offering of convertible senior notes. The notes, due in 2031, are a form of debt that can be turned into company stock. This news often worries investors because if the notes are converted, it could increase the number of shares and lessen the value of existing ones. The company also gave the initial buyers an option to purchase up to an additional $100 million in notes. Lucid stated that it planned to use most of the proceeds, about $752 million, to repurchase older convertible notes that were due in 2026. The rest of the funds were intended for general corporate purposes, effectively extending the company's debt maturity.

Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 5.7% in the afternoon session after several analysts raised their price targets for the company. 

Shares of online study and academic help platform Chegg (NYSE:CHGG) jumped 5.3% in the afternoon session after the company reported third-quarter results that showed better-than-expected profitability and a strategic shift toward its growing skilling business, overshadowing a steep drop in overall revenue. Total revenue fell by 42% year-over-year to $78 million, but the company surpassed its adjusted EBITDA guidance by $5 million due to cost-cutting efforts. Chegg announced it was restructuring into two units, with a focus on its "Chegg Skilling" division as the new growth engine. This segment, which includes professional courses, was on track for 14% year-over-year growth with a projected full-year revenue of $70 million. The company also announced the return of Dan Rosensweig as CEO to lead this strategic pivot. Investors appeared to focus on the company's improved operational management and the growth potential in the skilling market rather than the decline in its traditional academic services.

Cisco stock rose on fiscal first-quarter earnings and revenue that topped estimates amid strong artificial intelligence product orders.

SPY vs IVV: Which S&P 500 ETF Is Better for Investors?

Today, large volumes of short-term put options in Advanced Micro Devices stock imply that it might be overvalued. But a closer look at its strong free cash flow (FCF) and FCF margins could lead to a higher price target over the next year.

This fast-growing company is available at a very attractive valuation.

MSTR stock drops 60% as Bitcoin's decline impacts Strategy's valuation and mNAV approaches 1x, raising concerns over future moves.

The company returned to growth and has a ton of cash.

Jackson Square Buys 89,000 shares of HVAC Company AAON (Nasdaq: AAON) While Selling Nvidia

On 12 November, Automatic Data Processing increased its dividend by 10.39%, from $1.54 to $1.70 per share.

The global financial landscape is increasingly signaling a sustained upward trajectory for precious metals, with gold, silver, and platinum in particular exhibiting robust fundamentals that point towards a prolonged bull run. As of November 2025, market analysis indicates that escalating demand, fueled by a complex interplay of geopolitical instability, inflationary

As of November 12, 2025, the global financial markets are gripped by a perplexing and historically rare phenomenon: the Dow Jones Industrial Average (DJIA) has surged beyond the 48,000-point mark, signaling robust equity performance and investor optimism, while simultaneously, gold and silver prices have skyrocketed to unprecedented levels. This